Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis - Wikidata - awgldk - TriplyDB

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis

http://www.wikidata.org/entity/Q37481523

about

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation Hypersensitivity Responses in the Central Nervous System Update on biomarkers in neuromyelitis optica B Cells and Autoantibodies in Multiple Sclerosis Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort Antibody biomarkers in CNS demyelinating diseases - a long and winding road Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology The spectrum of MOG autoantibody-associated demyelinating diseases Biomarkers of treatment response in multiple sclerosis Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination.Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis.MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.Brain-reactive antibodies and disease.Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders Multi-Stage Mass Spectrometry Analysis of Sugar-Conjugated β-Turn Structures to be Used as Probes in Autoimmune Diseases.Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins Clinical and MRI phenotype of children with MOG antibodies Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species.Tolerogenic vaccines for Multiple sclerosis High-throughput flow cytometry cell-based assay to detect antibodies to N-methyl-D-aspartate receptor or dopamine-2 receptor in human serum Therapies for multiple sclerosis: considerations in the pediatric patient.

P2860

Q21146662-D076FA6A-3FDC-4721-871C-846365A7CB3A Q26770852-EF733A7D-580A-4438-AD09-9808F8E55CA2 Q26779177-796771A2-44BB-4B86-8549-3A8383E869FF Q26799789-0AF0F5AF-1015-4201-AD6D-5410E84E3590 Q26801386-0F1A5BFB-EB67-4909-8BDA-8322D19BBB53 Q28075974-41CDEDE8-0B08-42BE-9AEE-10656F78C391 Q28256650-A7EE10BC-A701-41A4-A784-CAC87D77651D Q28262403-003F5271-D61D-4A74-93EA-A3D1EA8F60CD Q28270042-1E318653-DC35-48FF-A7A4-601EAACB2E17 Q28293355-FA213CAA-45A3-4D53-8ABB-82AACA03B0C3 Q28305094-65FC7A72-1D0C-4F79-92C6-E12D4AECB529 Q28731829-21306BD3-3AD5-4FD7-8F85-CB11847E2E29 Q30723942-F5272696-E1BC-431D-9F9E-A8ACC180F496 Q33591024-404365C5-E966-44DF-A9D5-BD18F78498E5 Q33645795-E9E48227-106C-4E74-BD33-386693C3AAAC Q33770508-C80E5AEE-A749-420D-AC08-280A74E7856A Q33831179-E13CA106-6853-4D28-8480-D7F0E8307CF9 Q34306084-4E30F06F-43A3-4B5D-93EB-B8DDCABDB310 Q34368609-CA952BC8-639C-4961-8FE1-3ABD1C76925D Q34387874-44A8C937-7C54-4675-86AE-CA18C2FA3B4E Q34431835-49CC3066-29D0-4F79-B5E4-9961A1111180 Q34476320-916EB2D2-DE95-4FAE-AD02-FFF20BBC7A89 Q35208073-1069F1D6-2E3F-4FB9-BDF2-83D5954B0F68 Q35228937-D8938EA4-F088-45F4-947E-835DE099C92E Q35298764-B1FA0960-B42C-41DE-9845-3E4227C0A806 Q35458567-B9CB10F9-69CE-44F1-908F-69143897DB97 Q35542868-4C7003F8-9E85-42D8-8BC6-A309EEBFA3E7 Q35753620-BFFBA489-D032-4342-A71A-5E702DE66700 Q35884813-1FA62F74-146D-4BC8-B5C9-6856ECD37A68 Q35949316-04215109-292C-4601-B629-F93A041078ED Q35986699-57A7D425-BFEA-47EB-B962-8E9301670D97 Q36007039-BCF6058F-D2A4-40B9-BC00-96EC0A92C870 Q36330016-37C6BA22-4583-4DB8-BE06-5ED865899974 Q36345618-9B0363F5-8C96-4664-B931-C546D7BA888A Q37154797-472BF0CA-04AD-4398-9A3E-AF292CCB8337 Q37374434-6319249E-0815-4B7E-B6E4-0A17851AC9CF Q37467994-5DABFC84-FD91-457F-A4F7-68909162F409 Q37505364-534A5CC5-AD97-472C-A468-260555E9F8E2 Q37710749-41323CE9-375E-448F-BFA3-CE6CF4312EAC Q37827690-7BCCCBB6-117B-4C7F-95FF-C01A8673CF8A

P2860

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis

http://www.wikidata.org/entity/Q37481523

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Age-dependent B cell autoimmun ...... n pediatric multiple sclerosis

@en

Age-dependent B cell autoimmun ...... pediatric multiple sclerosis.

@nl

type

label

Age-dependent B cell autoimmun ...... n pediatric multiple sclerosis

@en

Age-dependent B cell autoimmun ...... pediatric multiple sclerosis.

@nl

prefLabel

Age-dependent B cell autoimmun ...... n pediatric multiple sclerosis

@en

Age-dependent B cell autoimmun ...... pediatric multiple sclerosis.

@nl

P1433

Q37481523-8548F9F0-3E4E-4D3C-8A59-3D70098C3F60

P1476

Q37481523-DE144D08-570B-4D49-96E8-0FE38E3A7C41

P2093

Q37481523-06E73A25-37B2-4805-9DCA-1DF281BAAD48

Q37481523-23126F01-288C-4C63-B759-7DC754809767

Q37481523-2682B727-91C6-4480-9F44-3A548191847A

Q37481523-28CB7B8B-5A41-4DBA-B784-F5C15EEC2057

Q37481523-357F561C-5C8D-4A18-B127-28AB8763A6B7

Q37481523-36AEAD08-FDEE-4BA0-AF12-9E769573AFEA

Q37481523-54C85630-861C-47F2-ABE2-A2769A99CA6A

Q37481523-6081A384-FCC1-449F-A94F-716B602F6970

Q37481523-6563CC8A-B436-43AE-8C39-F8F1C3A43969

Q37481523-7002E3E3-B378-46A1-9560-92689B6E17BD

P2860

Q37481523-00DE8984-C838-4208-9EEA-0085803A6AA5

Q37481523-14BBFA79-9C61-4310-80C2-E5194D7A11A4

Q37481523-2B55AAEB-D12F-473A-B709-D6FDC363972A

Q37481523-31E95962-ADF0-4E36-9553-9E00FE91DD42

Q37481523-35F62188-8A94-4330-9F0D-2AE942069A6D

Q37481523-40E52A78-F291-4561-9B8C-7BFC85A6B6AB

Q37481523-46C3297A-794A-4561-B43E-092EED3058FF

Q37481523-48640525-7DE0-4791-873D-6A5E2AC7C782

Q37481523-4CB5C840-ADD4-4D3D-A091-5EBEC99729F5

Q37481523-4E4614CA-1C06-4987-9F86-92C4E339C8A9

P304

Q37481523-24191DF4-0D77-4FE9-B1CF-6870683B71E4

P31

Q37481523-860FAD54-742C-4A3D-8402-40D21661E125

P356

Q37481523-F5FF9699-C469-4184-8FDA-46A7E27DEFD3

P407

Q37481523-C9F1AB32-261C-44FD-AB3F-52134125DA28

P433

Q37481523-C830F021-001E-4AA2-9C50-CDDF2698C548

P478

Q37481523-AF3E11B3-B5EE-470D-8237-AAD924D4083A

P50

Q37481523-5254F71C-C754-449F-96F3-04EE1F435834

Q37481523-993E2223-A74B-4E20-A4CB-62B0A742C21A

Q37481523-B71E087C-1377-4BD8-A3AD-9F1A73B7D5A5

P577

Q37481523-B7C79DF6-CA65-4D49-95B9-9DB06DA229DB

P5875

Q37481523-2C866142-8A67-4530-8AAA-BC28B955CA74

P698

Q37481523-108EF321-CEF6-4800-9EC2-F44B28574C4D

P921

Q37481523-8A2AE41A-74C6-478B-8F27-E5AB55EB6C3A

P932

Q37481523-2726D8DB-C1D9-4BC4-BECE-3BFCBAA0F4B5

P356

JIMMUNOL.0801888

P1433

Journal of Immunology

P1476

Age-dependent B cell autoimmun ...... n pediatric multiple sclerosis

@en

P2093

Amit Bar-Or

http://www.w3.org/2001/XMLSchema#string

Bettina Franz

http://www.w3.org/2001/XMLSchema#string

Brenda Banwell

http://www.w3.org/2001/XMLSchema#string

Daniela Pohl

http://www.w3.org/2001/XMLSchema#string

Donald Gagne

http://www.w3.org/2001/XMLSchema#string

Jayne M Ness

http://www.w3.org/2001/XMLSchema#string

Jens Kuhle

http://www.w3.org/2001/XMLSchema#string

Jerome de Seze

http://www.w3.org/2001/XMLSchema#string

Jia Newcombe

http://www.w3.org/2001/XMLSchema#string

Julia Kennedy

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Regulation of myelin oligodendrocyte glycoprotein in different species throughout development

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

Driver clones and determinant spreading.

P304

4067-4076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0801888

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P50

David A. Hafler

P577

2009-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26748166

http://www.w3.org/2001/XMLSchema#string

P698

19687098

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

2795331

http://www.w3.org/2001/XMLSchema#string